Skip to content

Study on the application of key techniques and collaborative diagnosis and treatment model for AIDS with fungal infection

Study on the application of key techniques and collaborative diagnosis and treatment model for AIDS with fungal infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078972
Enrollment
Unknown
Registered
2023-12-22
Start date
2024-01-31
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS with cryptococcal meningitis

Interventions

Cryptococcal meningitis routine treatment group:?Antifungal: According to the Chinese AIDS Diagnosis and Treatment Guidelines (2021 Edition), the induction period of amphotericin B was 0.5-0.7 mg/ (kg
?Continuous external drainage in the lumbocisternia was performed, and amphotericin B combined with dexamethasone was used for intrathecal injection. The specific regimen was AmB 0.1-1.0mg plus dexame
Cryptococcal meningitis intrathecal injection group:In the intervention group, amphotericin (AmB) was added intrathecal injection on top of basic antifungal therapy. Amphotericin B combined with dexam

Sponsors

Chest Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Central nervous system symptoms, These included elevated intracranial pressure (headache, vomiting, papilledema), cerebral hernia (bilateral dilated pupils, changes in respiratory rhythm, disturbance of consciousness, etc.), positive meningeal stimulation (Kernig, Brudzinski), and pathological reflex (Babinski, Chaddoc) Symptoms of brain parenchymal damage (paralysis, including monoplegia, hemiplegia, cross paralysis or chronic paralysis, convulsions, tremors, dance-like movements, etc.), symptoms of brain nerve damage (diplopia, facial paralysis, vision loss, etc.), symptoms of spinal cord damage (radicular pain, sensory and motor impairments below the damaged plane, etc.Cauda equina nerve injury, urinary retention or incontinence, constipation or incontinence, etc.), GCS score of more than 8 points; (2) High cranial pressure (>200 mmH2O); (3) Cerebrospinal fluid biochemical and routine abnormalities, positive cerebrospinal fluid etiology evidence, or skull imaging support

Exclusion criteria

Exclusion criteria: (1) The diagnosis is not clear (2) The condition is more serious (3) Refusal to sign informed consent

Design outcomes

Primary

MeasureTime frame
Cerebrospinal fluid cryptococcus detection;Cerebrospinal fluid cryptococcus count;Amphotericin concentration in cerebrospinal fluid;Vital sign;

Secondary

MeasureTime frame
Intracranial pressure;

Countries

China

Contacts

Public ContactShanfang Qin

Chest Hospital of Guangxi Zhuang Autonomous Region

2271976481@qq.com+86 137 6866 3088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026